These Adverse Events Linked to Improved Cancer Prognosis

TOPLINE: Cutaneous immune-related adverse events are associated with improved overall and progression-free survival among patients treated with immune checkpoint inhibitors (ICIs). METHODOLOGY: Emerging evidence...